Upgrade to SI Premium - Free Trial

Bristol-Myers Squibb (BMY), Bayer & Ono Pharma Report Collaboration Agreement to Investigate Stivarga (regorafenib) & Opdivo (nivolumab) as Combination Therapy

July 18, 2019 6:35 AM
Bayer, Bristol-Myers Squibb Company (NYSE: BMY) and Ono Pharmaceutical Co., Ltd. ("Ono") announced today the three companies have entered into ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA Management Comments

Next Articles